Сторінки без посилань

Наступні сторінки не містять посилань на інші сторінки цієї вікі.

Нижче показано до 20 результати у діапазоні від #31 до #50.

Переглянути (попередні 20 • наступні 20) (20 • 50 • 100 • 250 • 500).

31. (80.45 ) and 17 individuals 6 points (19.55 ). 5 sufferers (5.74 ) created liver decompensation for the duration of antiviral therapy.
32. (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
33. (80.45 ) and 17 individuals six points (19.55 ). 5 individuals (five.74 ) developed liver decompensation for the duration of antiviral therapy.
34. (80.45 ) and 17 individuals six points (19.55 ). Five individuals (5.74 ) created liver decompensation for the duration of antiviral therapy.
35. (80.45 ) and 17 patients 6 points (19.55 ). 5 individuals (5.74 ) developed liver decompensation in the course of antiviral therapy.
36. (80.45 ) and 17 patients 6 points (19.55 ). Five individuals (five.74 ) developed liver decompensation in the course of antiviral therapy.
37. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) created liver decompensation during antiviral therapy.
38. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
39. (80.45 ) and 17 patients 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation in the course of antiviral therapy.
40. (80.45 ) and 17 patients six points (19.55 ). 5 patients (five.74 ) created liver decompensation through antiviral therapy.
41. (80.45 ) and 17 patients six points (19.55 ). 5 sufferers (5.74 ) developed liver decompensation in the course of antiviral therapy.
42. (80.45 ) and 17 patients six points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
43. (80.45 ) and 17 sufferers 6 points (19.55 ). 5 sufferers (five.74 ) developed liver decompensation during antiviral therapy.
44. (80.45 ) and 17 sufferers 6 points (19.55 ). Five patients (5.74 ) developed liver decompensation during antiviral therapy.
45. (80.45 ) and 17 sufferers 6 points (19.55 ). Five sufferers (five.74 ) created liver decompensation for the duration of antiviral therapy.
46. (A) Stomatal closure in wild kind Col- (white bars) and ahk5-one (black bars) leaves 2.five h soon after exposure to escalating concentrations of H2O2
47. (E) Step three uses the Gamma parameter plane spanned by the shape
48. (F) Estimation of the number of viable cells at 48 and 96 h in P19 cells taken care of with .32 M CsA throughout EB formation
49. (Figure 1D). Infections with strains carrying welldefined mutations identified to exclusively
50. (GenBank accession no. DQ389174), which was reported to have low identity

Переглянути (попередні 20 • наступні 20) (20 • 50 • 100 • 250 • 500).